The new 52-week high list is a great place to look to spot the new leaders of any new bull market that may begin and can certainly tell you where capital is flowing.
So, with that tailwind in place, we are starting to allocate more capital in the sector as well. I’m beginning to trade some of the bigger and more liquid names. I successfully swing traded TWST this past week having bought a small position at $35.70 and sold several days later at $42.50 for a quick 19.0% gain. These types of moves will attract some of the momentum traders as the sector continues to gain strength. While these trades may be fun the big wins should come from accumulating bigger positions in solid companies with strong fundamentals. The smaller ones that aren’t on the radar screens of the early mover sophisticated investor.
My current favorite in the smaller space, and that fits most of the buying criteria we look for, is a name I’ve been nibbling on for several weeks now, Ceapro, CZO.V. We got quite a bit more aggressive this week and added a sizable amount at $0.56 and $0.57. We are adding Ceapro to our SCD portfolio and will start full coverage as soon as we can get all the details together.
Ceapro is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical and therapeutics products for humans and animals. The company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions.
The highlights are:
Closing price: $0.56
Shares outstanding: 77.7 million
Market cap: $43.5 million
Record Q1 revenues - grew revenues 31% in Q1
5 consecutive quarters of profitability
Grew profit by 288% in Q1
Trades at approximately 10.0 times trailing 12-month earnings
Healthy balance sheet – Over $8.7 million in cash, $13.6 million in working capital
Total liabilities: $3.3 million
Q1 gross margins 64%
Insider ownership; 8%
As I said we will get a report out with much more detail as soon as possible. In the meantime I will be looking to add to my position below $0.60
What we are keeping an eye on…..
Farmer protests are breaking out in many places around Europe. While for the time being these likely effects local economies this could turn into something bigger and it’s hard to predict what dominoes can be set off.
China/Taiwan – I’m trouble by how often I’m hearing from credible reports that tension is increasing between these 2 countries.
China steps up use of combat aircraft in Taiwan sorties as military tries to extend its reach
China Seeks to Pre-Empt Sanctions in Case of Taiwan Clash, F.B.I. Chief Says
We’ve seen the global economic and humanitarian impact from Russia’s invasion of Ukraine. An invasion of Taiwan by China would have a much greater impact. This could be a major “black swan” if a conflict erupts.
To your wealth,
Paul and Trevor